Biopharmaceutical Analytical Testing Services Market Analysis North America, APAC, Europe, South America, Middle East and Africa - US, China, Japan, UK, Germany - Size and Forecast 2023-2027

Published: Jan 2023 Pages: 171 SKU: IRTNTR40457

Biopharmaceutical Analytical Testing Services Market Forecast 2023-2027

The biopharmaceutical analytical testing services market size is forecast to increase by USD 3.45 billion at a CAGR of 12.61% between 2022 and 2027. The demand for monoclonal antibodies (mAbs) is rising alongside an increase in the number of patent-expired drugs and the prevalence of chronic diseases. However, the industry faces challenges including a shortage of trained professionals, changing formulations in product design, and the emergence of bioterrorism. This market analysis and report includes in-depth information on the key market drivers, trends, and challenges during the forecasted period. 

What will be the Size of the Biopharmaceutical Analytical Testing Services Market during the Forecast Period?

To learn more about this report, Download Report Sample

Biopharmaceutical development and drug discovery, meticulous attention to detail is paramount to ensure the safety and efficacy of pharmaceutical products. This necessitates comprehensive bioanalytical testing encompassing a myriad of aspects such as drug release testing, assessment of drug targets, and evaluation of biological fluids for metabolites and impurities. From the initial stages of biopharmaceutical R&D, where molecular understandings inform the development process, to the final stages of pharmaceutical components and mixtures, every step is crucial in safeguarding patient's health. Contract research organizations (CROs) play a pivotal role in conducting rigorous biotherapeutics testing, ensuring the integrity of proteins, compounds, and other drugs and therapeutics. Amidst concerns about the poor quality of medicines, robust fund systems support the advancement of biopharmaceutical science, facilitating breakthroughs that benefit global healthcare.

Market Dynamics 

In the realm of biopharmaceutical development, biopharmaceutical analytical plays a pivotal role in ensuring the safety, efficacy, and quality of novel therapeutics. Leveraging molecular understandings and advanced techniques, these services encompass a wide range of activities, including drug release testing and characterization of biotherapeutics. From identifying drug targets to assessing therapeutic potential, rigorous biopharmaceutical R&D protocols are followed to bring life-saving treatments to fruition. These services extend to various life sciences services, addressing critical aspects such as drug purity and the analysis of metabolites in biological fluids like blood, plasma, serum, urine, saliva, and tissue extracts. Adherence to regulatory frameworks such as ICH Q9, ICH Q8, and ICH Q10 ensures compliance and fosters trust in the industry's commitment to patient safety and well-being. From rheumatoid arthritis to oncology and infectious diseases, biopharmaceutical analytical testing services contribute to the development of innovative treatments, ultimately improving patient's health and addressing global health challenges.

Key Market Drivers

The increase in demand for mAbs is notably driving the biopharmaceutical analytical testing services market growth. mAbs are proteins developed in pharmaceutical and biotechnology laboratories to bind to the corresponding epitope of the antigen in the body. These antibodies are used as independent treatments or in combination with radiotherapy, drugs, or toxins to exterminate the infected cells.

The global mAbs market is growing, as mAbs are used for immunotherapy to stimulate immune responses to treat diseases. The rise in demand for personalized medicine is a major factor behind this demand. mAbs are subjected to several quality control tests, such as microbial tests, sterility tests, and dissolution tests to ensure their quality. Biopharmaceutical analytical testing services include product-related impurities information, structural characterization, and structural confirmation. Thus, the rise in demand for mAbs will increase the demand for analytical testing services, which, in turn, will fuel the growth of the healthcare analytical testing services market during the forecast period.

Significant Market Trends

The rise in investment in R&D is a key trend influencing the biopharmaceutical analytical testing services market growth. The expenditure on R&D is increasing globally. In developing countries, a large number of laboratories and research facilities are expected to be set up during the forecast period. This will increase the demand for analytical testing services to develop biopharmaceutical drugs.

The trend of increased R&D spending will last throughout the forecast period as countries are focusing on innovation. The increase in R&D leads to the expansion of facilities in fields such as drug discovery and pharmaceutical research, which depend on analytical testing services to develop safe and effective products. Hence, the growth of the pharmaceutical industry will lead to a rise in demand for biopharmaceutical analytical testing services during the forecast period. This, in turn, will support the growth of the global healthcare analytical testing services market. 

Major Market Challenges

The shortage of trained professionals may impede the biopharmaceutical analytical testing services market growth. The lack of required skilled professionals leads to a high degree of non-compliance. Improper testing and analysis of analytical tests can lead to product failures, which leads to losses for companies. The dearth of skilled professionals also affects the manufacturing process and, consequently, the quality of biopharmaceuticals.

According to the US Department of Labor, there is a shortage of approximately 12,000-15,000 laboratory professionals. Moreover, professionals currently working in laboratories are quitting their jobs or pursuing different fields in medicine. The attrition of laboratory professionals can be attributed to factors such as dissatisfaction with salaries, inadequate training programs, absence of job satisfaction, and lack of awareness about laboratory professions. The shortage of trained professionals is expected to continue during the forecast period, which, in turn, will impede the growth of the market.

Market Segment 

 The market research and growth report extensively covers market segmentation by Service (Bioanalytical, Method development and validation, Stability testing, Other), End-User (Pharma, Biotech companies, CROs), and Geography (North America, Europe, Asia, and Rest of World (ROW)). Furthermore, the market growth analysis report includes historic market data from 2017 to 2021. Pharmaceutical analytical testing outsourcing ensures the safety and efficacy of drugs like Cholera, Pertussis, and Influenza vaccines. Compliance with Good Laboratory Practices (GLP) and Good Clinical Practices (GCP) is essential for drug discovery and development. Analytical testing of biologics helps assess their efficacy and safety for the patient population, reducing disease burden. In the realm of healthcare, treatment of diseases such as heart disease, stroke, and chronic conditions remains paramount. This involves the development of custom-made medicine, including monoclonal drugs tailored to individual needs. Ensuring drug's safety and efficacy through rigorous biologics testing and clinical trial expenditures is essential. Additionally, virology testing and biomarker analysis aid in managing infectious diseases like HIV infections and Malaria. Advanced techniques like ICP-MS and physiochemical analysis contribute to understanding drug product quality and biological potency attributes. 

The Bioanalytical Segment is the Leading Segment to Dominate the Market

The market share growth by the bioanalytical segment will be significant during the forecast period and was valued at USD 0.85 billion in 2017 and continued to grow by 2021. Some of the major applications of techniques include bioavailability, pharmacology, bioequivalence, pharmacokinetic, and toxicology studies on humans and animals. The growth of this segment is expected to be driven by factors such as an increase in the use of biosimilars for a variety of medical indications, especially diabetes and cancer. Most contract research organizations (CROs), pharmaceutical companies, and bioanalytical laboratories are expanding their bioanalytical services and are investing in laboratories. Another driver for the growth of this segment is the outsourcing of R&D activities by pharmaceutical companies so that they can concentrate on their core competencies. New product development and innovation are expected to further increase the demand for services. This, in turn, is expected to expand the market growth and trends during the forecast period.

 Market  - Revenue Share by Service Segment, 2017 - 2027.   

For more details on other segments, Download Sample Report 

North America Holds a Prominent Position in the Market

North America is estimated to contribute 33% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period. North America has key companies, such as Charles River and Catalent, which are driving the growth of the market. These companies have a diversified portfolio of services, covering aspects of drug discovery, development, and manufacturing. The drugs need to be tested analytically according to the regulations to ensure safety, quality, and efficacy. The US and Canada are the key countries in the region, as stable economies and strong infrastructural support the launch of new drugs or biopharmaceuticals. High investments in R&D are further increasing the demand for high-quality analytical services in these countries. The rising prevalence of several diseases is increasing investments in clinical trials and research studies in the region. These factors are expected to drive the growth of the market in the region during the forecast period.

Market Size, By Region, Global, 2017 -  2027.   

To understand geographic trends Download Market Report Sample

Companies Overview

The Biopharmaceutical Analytical Testing Services market is fragmented in nature. Some significant players include Almac Group Ltd.

This market research and growth report also includes detailed analyses of the competitive landscape of the market and information about 15 market companies, including:

Boston Analytical, Catalent Inc., Charles River Laboratories International Inc., Coriolis Pharma Research GmbH, Curia Inc., Element Materials Technology Group Ltd., Eurofins Scientific SE, ICON plc, Intertek Group Plc, Laboratory Corp. of America Holdings, Merck KGaA, Pace Analytical Services LLC, Parexel International Corp., SGS SA, Solvias AG, STERIS Plc, Thermo Fisher Scientific Inc., Vimta Labs Ltd., and West Pharmaceutical Services Inc.

Research Analyst Overview

The market plays a pivotal role in drug development and approval processes, addressing the increasing complexity of therapeutics. Outsourcing testing services, particularly for gene therapies and biologics, is prevalent among pharmaceutical and biotechnology companies, involving specialized firms for enhanced efficiency. Technological advancements, including high-throughput screening methods, automation, and advanced analytical techniques, ensure accuracy and speed in bioanalytical testing. The market accommodates combination products and innovative medicines, facilitating the outsourcing of R&D activities for economic efficiency amidst competitive pressure and pricing concerns. Consumer interest in self-care underscores the importance of accessibility to bioanalytical testing services, balancing in-house tests and outsourcing based on testing capabilities.

Stringent regulatory compliance requirements uphold the safety and effectiveness of drugs and therapies, addressing molecules ranging from small to large, fostering medical breakthroughs, and meeting unmet medical needs. Chemical probes, PK, pharmacodynamics, generic and branded drug compounds, and patent expiration contribute to the workflow, encompassing sample analysis, quantitation of impurities, stability of drug molecules, identification of impurities, sample preparation, extraction procedures, and nontraditional extraction technologies. Automation aids in reducing cost use, enabling miniaturization while focusing on Absorption Distribution Metabolism Excretion (ADME), Pharmacokinetics (PK), Pharmacodynamics (PD), and other test types. Moreover, market concentration drives advancements in chromatography, mass spectrometry, and immunoassays, supporting the development of cost-efficient generics or biosimilars such as Ustekinumab Biosimilar (BFI-751).

Segment Overview

The market analysis and report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 - 2027.   

  • Service Outlook
    • Bioanalytical 
    • Method development and validation
    • Stability testing
    • Others 
  • End-user Outlook
    • Pharma
    •  Biotech companies
    • CROs 
  • Region Outlook
    • North America
      • The U.S.
      • Canada
    • Europe
      • The U.K.
      • Germany
      • France
      • Rest of Europe
    • APAC
      • China
      • India
    • Middle East & Africa
      • Saudi Arabia
      • South Africa
      • Rest of the Middle East & Africa
    • South America
      • Argentina
      • Brazil
      • Chile

Market Scope

Report Coverage

Details

Page number

171

Base year

2022

Historic period

2017 - 2021

Forecast period

2023-2027

Growth momentum & CAGR

Accelerate at a CAGR of 12.61%

Market growth 2023-2027

USD 3.45 billion

Market structure

USD Fragmented

YoY growth 2022-2023(%)

11.67

Regional analysis

North America, APAC, Europe, South America, and Middle East and Africa

Performing market contribution

North America at 33%

Key countries

US, China, Japan, UK, and Germany

Competitive landscape

 Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks

Key companies profiled

Almac Group Ltd., Boston Analytical, Catalent Inc., Charles River Laboratories International Inc., Coriolis Pharma Research GmbH, Curia Inc., Element Materials Technology Group Ltd., Eurofins Scientific SE, ICON plc, Intertek Group Plc, Laboratory Corp. of America Holdings, Merck KGaA, Pace Analytical Services LLC, Parexel International Corp., SGS SA, Solvias AG, STERIS Plc, Thermo Fisher Scientific Inc., Vimta Labs Ltd., and West Pharmaceutical Services Inc.

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, Market growth and Forecasting, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

View PDF Sample

What are the Key Data Covered in this Market Research Report?

  • CAGR of the market during the forecast period
  • Detailed information on factors that will drive the market growth and forecasting between 2023 and 2027
  • Precise estimation of the size of the market  size and its contribution of the market in focus to the parent market
  • Accurate predictions about upcoming trends and changes in consumer behavior
  • Market growth analysis industry across North America, APAC, Europe, South America, and Middle East and Africa
  • Thorough analysis of the market’s competitive landscape and detailed information about companies
  • Market forecasting of factors that will challenge the growth of market companies

We can help! Our analysts can customize this market research report to meet your requirements. 

Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Service
    • Exhibit 06: Executive Summary – Chart on Market Segmentation by End-user
    • Exhibit 07: Executive Summary – Chart on Incremental Growth
    • Exhibit 08: Executive Summary – Data Table on Incremental Growth
    • Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 10: Parent market
    • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 13: Market segments
  • 3.3 Market size 2022
    • 3.4 Market outlook: Forecast for 2022-2027
      • Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
      • Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
      • Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
      • Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

    4 Historic Market Size

    • 4.1 Global biopharmaceutical analytical testing services market 2017 - 2021
      • Exhibit 18: Historic Market Size – Data Table on Global biopharmaceutical analytical testing services market 2017 - 2021 ($ million)
    • 4.2 Service Segment Analysis 2017 - 2021
      • Exhibit 19: Historic Market Size – Service Segment 2017 - 2021 ($ million)
    • 4.3 End-user Segment Analysis 2017 - 2021
      • Exhibit 20: Historic Market Size – End-user Segment 2017 - 2021 ($ million)
    • 4.4 Geography Segment Analysis 2017 - 2021
      • Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ million)
    • 4.5 Country Segment Analysis 2017 - 2021
      • Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ million)

    5 Five Forces Analysis

    • 5.1 Five forces summary
      • Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
    • 5.2 Bargaining power of buyers
      • Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
    • 5.3 Bargaining power of suppliers
      • Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
    • 5.4 Threat of new entrants
      • Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
    • 5.5 Threat of substitutes
      • Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
    • 5.6 Threat of rivalry
      • Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
    • 5.7 Market condition
      • Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

    6 Market Segmentation by Service

    • 6.1 Market segments
      • Exhibit 30: Chart on Service - Market share 2022-2027 (%)
      • Exhibit 31: Data Table on Service - Market share 2022-2027 (%)
    • 6.2 Comparison by Service
      • Exhibit 32: Chart on Comparison by Service
      • Exhibit 33: Data Table on Comparison by Service
    • 6.3 Bioanalytical - Market size and forecast 2022-2027
      • Exhibit 34: Chart on Bioanalytical - Market size and forecast 2022-2027 ($ million)
      • Exhibit 35: Data Table on Bioanalytical - Market size and forecast 2022-2027 ($ million)
      • Exhibit 36: Chart on Bioanalytical - Year-over-year growth 2022-2027 (%)
      • Exhibit 37: Data Table on Bioanalytical - Year-over-year growth 2022-2027 (%)
    • 6.4 Method development and validation - Market size and forecast 2022-2027
      • Exhibit 38: Chart on Method development and validation - Market size and forecast 2022-2027 ($ million)
      • Exhibit 39: Data Table on Method development and validation - Market size and forecast 2022-2027 ($ million)
      • Exhibit 40: Chart on Method development and validation - Year-over-year growth 2022-2027 (%)
      • Exhibit 41: Data Table on Method development and validation - Year-over-year growth 2022-2027 (%)
    • 6.5 Stability testing - Market size and forecast 2022-2027
      • Exhibit 42: Chart on Stability testing - Market size and forecast 2022-2027 ($ million)
      • Exhibit 43: Data Table on Stability testing - Market size and forecast 2022-2027 ($ million)
      • Exhibit 44: Chart on Stability testing - Year-over-year growth 2022-2027 (%)
      • Exhibit 45: Data Table on Stability testing - Year-over-year growth 2022-2027 (%)
    • 6.6 Others - Market size and forecast 2022-2027
      • Exhibit 46: Chart on Others - Market size and forecast 2022-2027 ($ million)
      • Exhibit 47: Data Table on Others - Market size and forecast 2022-2027 ($ million)
      • Exhibit 48: Chart on Others - Year-over-year growth 2022-2027 (%)
      • Exhibit 49: Data Table on Others - Year-over-year growth 2022-2027 (%)
    • 6.7 Market opportunity by Service
      • Exhibit 50: Market opportunity by Service ($ million)

    7 Market Segmentation by End-user

    • 7.1 Market segments
      • Exhibit 51: Chart on End-user - Market share 2022-2027 (%)
      • Exhibit 52: Data Table on End-user - Market share 2022-2027 (%)
    • 7.2 Comparison by End-user
      • Exhibit 53: Chart on Comparison by End-user
      • Exhibit 54: Data Table on Comparison by End-user
    • 7.3 Pharma and biotech companies - Market size and forecast 2022-2027
      • Exhibit 55: Chart on Pharma and biotech companies - Market size and forecast 2022-2027 ($ million)
      • Exhibit 56: Data Table on Pharma and biotech companies - Market size and forecast 2022-2027 ($ million)
      • Exhibit 57: Chart on Pharma and biotech companies - Year-over-year growth 2022-2027 (%)
      • Exhibit 58: Data Table on Pharma and biotech companies - Year-over-year growth 2022-2027 (%)
    • 7.4 CROs - Market size and forecast 2022-2027
      • Exhibit 59: Chart on CROs - Market size and forecast 2022-2027 ($ million)
      • Exhibit 60: Data Table on CROs - Market size and forecast 2022-2027 ($ million)
      • Exhibit 61: Chart on CROs - Year-over-year growth 2022-2027 (%)
      • Exhibit 62: Data Table on CROs - Year-over-year growth 2022-2027 (%)
    • 7.5 Market opportunity by End-user
      • Exhibit 63: Market opportunity by End-user ($ million)

    8 Customer Landscape

    • 8.1 Customer landscape overview
      • Exhibit 64: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    9 Geographic Landscape

    • 9.1 Geographic segmentation
      • Exhibit 65: Chart on Market share by geography 2022-2027 (%)
      • Exhibit 66: Data Table on Market share by geography 2022-2027 (%)
    • 9.2 Geographic comparison
      • Exhibit 67: Chart on Geographic comparison
      • Exhibit 68: Data Table on Geographic comparison
    • 9.3 North America - Market size and forecast 2022-2027
      • Exhibit 69: Chart on North America - Market size and forecast 2022-2027 ($ million)
      • Exhibit 70: Data Table on North America - Market size and forecast 2022-2027 ($ million)
      • Exhibit 71: Chart on North America - Year-over-year growth 2022-2027 (%)
      • Exhibit 72: Data Table on North America - Year-over-year growth 2022-2027 (%)
    • 9.4 APAC - Market size and forecast 2022-2027
      • Exhibit 73: Chart on APAC - Market size and forecast 2022-2027 ($ million)
      • Exhibit 74: Data Table on APAC - Market size and forecast 2022-2027 ($ million)
      • Exhibit 75: Chart on APAC - Year-over-year growth 2022-2027 (%)
      • Exhibit 76: Data Table on APAC - Year-over-year growth 2022-2027 (%)
    • 9.5 Europe - Market size and forecast 2022-2027
      • Exhibit 77: Chart on Europe - Market size and forecast 2022-2027 ($ million)
      • Exhibit 78: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
      • Exhibit 79: Chart on Europe - Year-over-year growth 2022-2027 (%)
      • Exhibit 80: Data Table on Europe - Year-over-year growth 2022-2027 (%)
    • 9.6 South America - Market size and forecast 2022-2027
      • Exhibit 81: Chart on South America - Market size and forecast 2022-2027 ($ million)
      • Exhibit 82: Data Table on South America - Market size and forecast 2022-2027 ($ million)
      • Exhibit 83: Chart on South America - Year-over-year growth 2022-2027 (%)
      • Exhibit 84: Data Table on South America - Year-over-year growth 2022-2027 (%)
    • 9.7 Middle East and Africa - Market size and forecast 2022-2027
      • Exhibit 85: Chart on Middle East and Africa - Market size and forecast 2022-2027 ($ million)
      • Exhibit 86: Data Table on Middle East and Africa - Market size and forecast 2022-2027 ($ million)
      • Exhibit 87: Chart on Middle East and Africa - Year-over-year growth 2022-2027 (%)
      • Exhibit 88: Data Table on Middle East and Africa - Year-over-year growth 2022-2027 (%)
    • 9.8 US - Market size and forecast 2022-2027
      • Exhibit 89: Chart on US - Market size and forecast 2022-2027 ($ million)
      • Exhibit 90: Data Table on US - Market size and forecast 2022-2027 ($ million)
      • Exhibit 91: Chart on US - Year-over-year growth 2022-2027 (%)
      • Exhibit 92: Data Table on US - Year-over-year growth 2022-2027 (%)
    • 9.9 China - Market size and forecast 2022-2027
      • Exhibit 93: Chart on China - Market size and forecast 2022-2027 ($ million)
      • Exhibit 94: Data Table on China - Market size and forecast 2022-2027 ($ million)
      • Exhibit 95: Chart on China - Year-over-year growth 2022-2027 (%)
      • Exhibit 96: Data Table on China - Year-over-year growth 2022-2027 (%)
    • 9.10 Japan - Market size and forecast 2022-2027
      • Exhibit 97: Chart on Japan - Market size and forecast 2022-2027 ($ million)
      • Exhibit 98: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
      • Exhibit 99: Chart on Japan - Year-over-year growth 2022-2027 (%)
      • Exhibit 100: Data Table on Japan - Year-over-year growth 2022-2027 (%)
    • 9.11 UK - Market size and forecast 2022-2027
      • Exhibit 101: Chart on UK - Market size and forecast 2022-2027 ($ million)
      • Exhibit 102: Data Table on UK - Market size and forecast 2022-2027 ($ million)
      • Exhibit 103: Chart on UK - Year-over-year growth 2022-2027 (%)
      • Exhibit 104: Data Table on UK - Year-over-year growth 2022-2027 (%)
    • 9.12 Germany - Market size and forecast 2022-2027
      • Exhibit 105: Chart on Germany - Market size and forecast 2022-2027 ($ million)
      • Exhibit 106: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
      • Exhibit 107: Chart on Germany - Year-over-year growth 2022-2027 (%)
      • Exhibit 108: Data Table on Germany - Year-over-year growth 2022-2027 (%)
    • 9.13 Market opportunity by geography
      • Exhibit 109: Market opportunity by geography ($ million)

    10 Drivers, Challenges, and Trends

    • 10.1 Market drivers
      • 10.2 Market challenges
        • 10.3 Impact of drivers and challenges
          • Exhibit 110: Impact of drivers and challenges in 2022 and 2027
        • 10.4 Market trends

          11 Vendor Landscape

          • 11.1 Overview
            • 11.2 Vendor landscape
              • Exhibit 111: Overview on Criticality of inputs and Factors of differentiation
            • 11.3 Landscape disruption
              • Exhibit 112: Overview on factors of disruption
            • 11.4 Industry risks
              • Exhibit 113: Impact of key risks on business

            12 Vendor Analysis

            • 12.1 Vendors covered
              • Exhibit 114: Vendors covered
            • 12.2 Market positioning of vendors
              • Exhibit 115: Matrix on vendor position and classification
            • 12.3 Almac Group Ltd.
              • Exhibit 116: Almac Group Ltd. - Overview
              • Exhibit 117: Almac Group Ltd. - Product / Service
              • Exhibit 118: Almac Group Ltd. - Key offerings
            • 12.4 Boston Analytical
              • Exhibit 119: Boston Analytical - Overview
              • Exhibit 120: Boston Analytical - Product / Service
              • Exhibit 121: Boston Analytical - Key news
              • Exhibit 122: Boston Analytical - Key offerings
            • 12.5 Catalent Inc.
              • Exhibit 123: Catalent Inc. - Overview
              • Exhibit 124: Catalent Inc. - Business segments
              • Exhibit 125: Catalent Inc. - Key news
              • Exhibit 126: Catalent Inc. - Key offerings
              • Exhibit 127: Catalent Inc. - Segment focus
            • 12.6 Charles River Laboratories International Inc.
              • Exhibit 128: Charles River Laboratories International Inc. - Overview
              • Exhibit 129: Charles River Laboratories International Inc. - Business segments
              • Exhibit 130: Charles River Laboratories International Inc. - Key news
              • Exhibit 131: Charles River Laboratories International Inc. - Key offerings
              • Exhibit 132: Charles River Laboratories International Inc. - Segment focus
            • 12.7 Coriolis Pharma Research GmbH
              • Exhibit 133: Coriolis Pharma Research GmbH - Overview
              • Exhibit 134: Coriolis Pharma Research GmbH - Product / Service
              • Exhibit 135: Coriolis Pharma Research GmbH - Key offerings
            • 12.8 Element Materials Technology Group Ltd.
              • Exhibit 136: Element Materials Technology Group Ltd. - Overview
              • Exhibit 137: Element Materials Technology Group Ltd. - Product / Service
              • Exhibit 138: Element Materials Technology Group Ltd. - Key offerings
            • 12.9 Eurofins Scientific SE
              • Exhibit 139: Eurofins Scientific SE - Overview
              • Exhibit 140: Eurofins Scientific SE - Business segments
              • Exhibit 141: Eurofins Scientific SE - Key news
              • Exhibit 142: Eurofins Scientific SE - Key offerings
              • Exhibit 143: Eurofins Scientific SE - Segment focus
            • 12.10 ICON plc
              • Exhibit 144: ICON plc - Overview
              • Exhibit 145: ICON plc - Product / Service
              • Exhibit 146: ICON plc - Key offerings
            • 12.11 Intertek Group Plc
              • Exhibit 147: Intertek Group Plc - Overview
              • Exhibit 148: Intertek Group Plc - Business segments
              • Exhibit 149: Intertek Group Plc - Key news
              • Exhibit 150: Intertek Group Plc - Key offerings
              • Exhibit 151: Intertek Group Plc - Segment focus
            • 12.12 Merck KGaA
              • Exhibit 152: Merck KGaA - Overview
              • Exhibit 153: Merck KGaA - Business segments
              • Exhibit 154: Merck KGaA - Key news
              • Exhibit 155: Merck KGaA - Key offerings
              • Exhibit 156: Merck KGaA - Segment focus
            • 12.13 Pace Analytical Services LLC
              • Exhibit 157: Pace Analytical Services LLC - Overview
              • Exhibit 158: Pace Analytical Services LLC - Product / Service
              • Exhibit 159: Pace Analytical Services LLC - Key offerings
            • 12.14 SGS SA
              • Exhibit 160: SGS SA - Overview
              • Exhibit 161: SGS SA - Business segments
              • Exhibit 162: SGS SA - Key offerings
              • Exhibit 163: SGS SA - Segment focus
            • 12.15 Solvias AG
              • Exhibit 164: Solvias AG - Overview
              • Exhibit 165: Solvias AG - Product / Service
              • Exhibit 166: Solvias AG - Key news
              • Exhibit 167: Solvias AG - Key offerings
            • 12.16 STERIS Plc
              • Exhibit 168: STERIS Plc - Overview
              • Exhibit 169: STERIS Plc - Business segments
              • Exhibit 170: STERIS Plc - Key news
              • Exhibit 171: STERIS Plc - Key offerings
              • Exhibit 172: STERIS Plc - Segment focus
            • 12.17 West Pharmaceutical Services Inc.
              • Exhibit 173: West Pharmaceutical Services Inc. - Overview
              • Exhibit 174: West Pharmaceutical Services Inc. - Business segments
              • Exhibit 175: West Pharmaceutical Services Inc. - Key news
              • Exhibit 176: West Pharmaceutical Services Inc. - Key offerings
              • Exhibit 177: West Pharmaceutical Services Inc. - Segment focus

            13 Appendix

            • 13.1 Scope of the report
              • 13.2 Inclusions and exclusions checklist
                • Exhibit 178: Inclusions checklist
                • Exhibit 179: Exclusions checklist
              • 13.3 Currency conversion rates for US$
                • Exhibit 180: Currency conversion rates for US$
              • 13.4 Research methodology
                • Exhibit 181: Research methodology
                • Exhibit 182: Validation techniques employed for market sizing
                • Exhibit 183: Information sources
              • 13.5 List of abbreviations
                • Exhibit 184: List of abbreviations
              • Stability and Storage
                • growth due to the increasing number of tests for infectious and chronic diseases: The incidence of infectious and chronic diseases has increased over the past decade. The outbreak of the COVID-19 pandemic in 2020 has increased the demand for laboratory testing for COVID-19 across the world. An increase in demand for laboratory testing for infectious diseases, such as COVID-19 and chronic diseases, will be a driver for the life sciences tools and services industry in the future. The growth of the tools and services industry will continue to be strong in emerging markets such as China and India. Developed economies such as Japan and the EU will exhibit moderate growth rates.
                  • product development to decrease prices: As the pricing pressure increases, life sciences tools manufacturers will have to rethink product development processes. A value first product design philosophy can help control costs and deliver what customers value the most.

                    Research Framework

                    Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

                    INFORMATION SOURCES

                    Primary sources

                    • Manufacturers and suppliers
                    • Channel partners
                    • Industry experts
                    • Strategic decision makers

                    Secondary sources

                    • Industry journals and periodicals
                    • Government data
                    • Financial reports of key industry players
                    • Historical data
                    • Press releases

                    DATA ANALYSIS

                    Data Synthesis

                    • Collation of data
                    • Estimation of key figures
                    • Analysis of derived insights

                    Data Validation

                    • Triangulation with data models
                    • Reference against proprietary databases
                    • Corroboration with industry experts

                    REPORT WRITING

                    Qualitative

                    • Market drivers
                    • Market challenges
                    • Market trends
                    • Five forces analysis

                    Quantitative

                    • Market size and forecast
                    • Market segmentation
                    • Geographical insights
                    • Competitive landscape

                    PURCHASE FULL REPORT OF

                    biopharmaceutical analytical testing services market market

                    QUICK BUY

                    Key Questions Answered

                    • What are the key global market and the regional market share?
                    • What are the revenue-generating key market segments?
                    • What are the key factors driving and challenging this market’s growth?
                    • Who are the key market vendors and their growth strategies?
                    • What are the latest trends influencing the growth of this market?
                    • What are the variables influencing the market growth in the primary regions?
                    • What are the factors influencing the growth of the parent market?

                    Why should you prefer Technavio's market insights report?

                    • Off-the-shelf research reports
                    • Reports can be tailored to meet the customer's needs
                    • Trusted by more than 100 fortune 500 organizations
                    • Information about the market's key drivers, trends, and challenges
                    • Parent market analysis
                    • Every week, 50,000 people visit our subscription platform
                    • Detailed vendors report with competitive landscape
                    • Covid-19 impact and recovery analysis
                    • Data on revenue-generating market segments
                    • Details on the market shares of various regions
                    • Five-force market analysis